Ming Yao
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 53
- Hematopoietic Stem Cell Transplantation 14
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 25
- Chronic Lymphocytic Leukemia Research 12
- Biomaterials top 1%
- Molecular Biology top 1%
- RNA modifications and cancer 14
- Cancer Research top 2%
-
- Lymphoma Diagnosis and Treatment 27
-
- Viral-associated cancers and disorders 22
-
- Hepatitis C virus research 12
- Co-authors
- Hwei‐Fang TienJih‐Luh TangYao‐Chang ChenDongming HuangWoei TsayYee‐Chun ChenBor‐Sheng KoWen‐Chien Chou
- Cited by
- HematologyGeneticsBiomaterials
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Ming Yao
343 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Hematology 2.4k
- Genetics 1.4k
- Biomaterials 987
- Molecular Biology 4.0k
- Cancer Research 842
Countries citing papers authored by Ming Yao
This map shows the geographic impact of Ming Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Yao more than expected).
Fields of papers citing papers by Ming Yao
This network shows the impact of papers produced by Ming Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Yao. The network helps show where Ming Yao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 23 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 11 | |
| 14 | The Relationship Among Organizational Identity, Psychological Resilience and Work Engagement of the First-Line Nurses in the Prevention and Control of COVID-19 Based on Structural Equation Model | 2020 | 0 |
| 15 | Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma | 2019 | 1 |
| 16 | Personalized needle modification for CT-guided percutaneous infrazygomatic radiofrequency ablation of the maxillary nerve through the foramen rotundum in order to treat V2 trigeminal neuralgia | 2019 | 1 |
| 17 | Development and evaluation of vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical | 2016 | 5 |
| 18 | Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies | 2012 | 5 |
| 19 | 2006 | 115 | |
| 20 | High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan. | 2002 | 8 |
About Ming Yao
Ming Yao is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 360 papers that have together received 9.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (53 papers), Lymphoma Diagnosis and Treatment (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers), Viral-associated cancers and disorders (22 papers), RNA modifications and cancer (14 papers), Hematopoietic Stem Cell Transplantation (14 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Hepatitis C virus research (12 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (1.4k citations), Biomaterials (987 citations), Molecular Biology (4.0k citations) and Cancer Research (842 citations). Ming Yao has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Hwei‐Fang Tien, Jih‐Luh Tang, Yao‐Chang Chen, Dongming Huang, Woei Tsay, Yee‐Chun Chen, Bor‐Sheng Ko, Wen‐Chien Chou, Shang‐Yi Huang and Chien‐Yuan Chen. Their work appears in journals such as Blood, Annals of Hematology, Leukemia, British Journal of Haematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.